<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092023000700582</article-id>
<article-id pub-id-type="doi">10.35366/114860</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Asociación del índice TAPSE/PSAP y mortalidad en pacientes ingresados a la terapia intensiva con disfunción ventricular derecha tratados con levosimendán]]></article-title>
<article-title xml:lang="en"><![CDATA[Association of the TAPSE/PSAP index and mortality in patients admitted to intensive care with right ventricular dysfunction treated with levosimendan]]></article-title>
<article-title xml:lang="pt"><![CDATA[Associação do índice TAPSE/PSAP e mortalidade em pacientes internados na unidade de terapia intensiva com disfunção ventricular direita tratados com levosimendan]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Núñez González]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gaytán García]]></surname>
<given-names><![CDATA[Cristhian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Marcos]]></surname>
<given-names><![CDATA[Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mora Ruiz]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguirre Sánchez]]></surname>
<given-names><![CDATA[Janet Silvia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Díaz]]></surname>
<given-names><![CDATA[Braulia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico ABC  ]]></institution>
<addr-line><![CDATA[CDMX ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>37</volume>
<numero>7</numero>
<fpage>582</fpage>
<lpage>592</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092023000700582&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092023000700582&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092023000700582&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  para evaluar la disfunción ventricular derecha, se utilizan medidas como el TAPSE y la PSAP, cuya relación (TAPSE/PSAP) puede ser predictora de mortalidad hospitalaria. Por otro lado, el levosimendán es un fármaco que se usa comúnmente en la insuficiencia cardiaca izquierda, y que también puede ser efectivo en el tratamiento de la insuficiencia ventricular derecha. Sin embargo, la evidencia disponible es contradictoria respecto a la asociación entre el uso de levosimendán, los parámetros de disfunción ventricular derecha y la mortalidad hospitalaria.  Objetivo:  evaluar la asociación del índice TAPSE/PSAP &#8804; 0.31 mm/mmHg y la mortalidad en pacientes que ingresan a la Unidad de Medicina Crítica con disfunción ventricular derecha que recibieron levosimendán.  Material y métodos:  cohorte retrospectiva, una muestra consecutiva de pacientes mayores de edad, hasta alcanzar el tamaño de muestra de 54, con diagnóstico de falla cardiaca derecha aguda por cualquier etiología que hayan sido ingresados a la Unidad de Medicina Crítica, que recibieron por lo menos una dosis de levosimendán con ecocardiograma (TAPSE, PSAP). Se asoció TAPSE/PSAP con la mortalidad hospitalaria.  Resultados:  incluimos a 78 pacientes de los cuales la mayoría (43, 55.1%) eran hombres, mediana de 73 años (18-95), comorbilidades más comunes: diabetes (25.6%) e hipertensión arterial (55.1%%); la sepsis (43, 55.1%) fue el diagnóstico más común. El índice TAPSE/PSAP fue &gt; 0.32 en la mayoría de los pacientes (65.3%), mediana de 0.32 (rango 0.107-0.771). Veinticuatro pacientes (30.8%) fallecieron. Las mediciones del TAPSE, el índice TAPSE/PSAP, SOFA, los días de levosimendán fueron similares entre los pacientes que fallecieron y vivieron.  Conclusiones:  este estudio evaluó la utilidad del índice TAPSE/PSAP &lt; 31 mm/mmHg como predictor de mortalidad en pacientes en la Unidad de Cuidados Intensivos con disfunción ventricular derecha que recibieron tratamiento con levosimendán, este índice no es un marcador fiable para predecir el riesgo de mortalidad en esta población (OR 0.921, IC95% 0.333-2.544, r2 0.0).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  to evaluate right ventricular dysfunction, measures such as TAPSE and PSAP are used, whose ratio (TAPSE/PSAP) can be predictors of in-hospital mortality. On the other hand, levosimendan is a drug that is commonly used in left heart failure, and may also be effective in the treatment of right ventricular failure. However, the available evidence is contradictory regarding the association between the use of levosimendan, right ventricular dysfunction parameters, and in-hospital mortality.  Objective:  to evaluate the association of the TAPSE/PSAP index &#8804; 0.31 mm/mmHg and mortality in patients admitted to the Critical Care Medicine Unit with right ventricular dysfunction who received levosimendan.  Material and methods:  retrospective cohort, a consecutive sample of patients of legal age, until reaching the sample size of 54, with a diagnosis of acute right heart failure due to any etiology who have been admitted to the Critical Care Medicine Unit, who received at least minus one dose of levosimendan with echocardiogram (TAPSE, PSAP). TAPSE/PSAP was associated with in-hospital mortality.  Results:  we included 78 patients of which the majority (43, 55.1%) were men, median age 73 years (18-95), most common comorbidities: diabetes (25.6%) and arterial hypertension (55.1%), sepsis (43, 55.1%) was the most common diagnosis. The TAPSE/PSAP index was &gt; 0.32 in the majority of patients (65.3%), median 0.32 (range 0.107-0.771). Twenty-four patients (30.8%) died. Measurements of TAPSE, TAPSE/PSAP index, SOFA, and days on levosimendan were similar between patients who died and those who lived.  Conclusions:  this study evaluated the usefulness of the TAPSE/PSAP index with a cut-off point &lt; 31 mm/mmHg as a predictor of mortality in patients in the Intensive Care Unit with right ventricular dysfunction who received treatment with Levosimendan. The results suggest that this index is not a reliable marker to predict the risk of mortality in this population (OR 0.921, 95% CI 0.333-2.544, r2 0.0).]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  para avaliar a disfunção ventricular direita são utilizadas medidas como TAPSE e PSAP, cuja relação (TAPSE/PSAP) pode ser preditora de mortalidade hospitalar. Por outro lado, o levosimendan é um medicamento comumente utilizado na insuficiência cardíaca esquerda, podendo também ser eficaz no tratamento da insuficiência ventricular direita. Entretanto, a evidência disponível é contraditória quanto à associação entre o uso de levosimendan, parâmetros de disfunção ventricular direita e mortalidade hospitalar.  Objetivo:  avaliar a associação do índice TAPSE/PSAP &#8804; 0.31 mm/mmHg e a mortalidade em pacientes internados na Unidade de Terapia Intensiva com disfunção ventricular direita que receberam levosimendan.  Material e métodos:  coorte retrospectiva, amostra consecutiva de pacientes maiores de idade, até atingir o tamanho amostra de 54, com diagnóstico de insuficiência cardíaca direita aguda de qualquer etiologia, internados na Unidade de Terapia Intensiva, que receberam em pelo menos uma dose de levosimendan com ecocardiograma (TAPSE, PSAP). Associou-se o TAPSE/PSAP à mortalidade hospitalar.  Resultados:  incluíram-se 78 pacientes, dos quais a maioria (43, 55.1%) eram homens, idade média de 73 anos (18-95), comorbidades mais comuns: diabetes (25.6%) e hipertensão arterial (55.1%), sepse (43, 55.1%) foi o diagnóstico mais comum. O índice TAPSE/PSAP foi &gt; 0.32 na maioria dos pacientes (65.3%), mediana 0.32 (intervalo 0.107-0.771). Vinte e quatro pacientes (30.8%) faleceram. As medidas de TAPSE, índice TAPSE/PSAP, SOFA, os dias de levosimendan foram semelhantes entre pacientes que faleceram e sobreviveram.  Conclusões:  este estudo avaliou a utilidade do índice TAPSE/PSAP &lt; 31 mm/mmHg como preditor de mortalidade em pacientes internados na Unidade de Terapia Intensiva com disfunção ventricular direita que receberam tratamento com levosimendan, este índice não é um marcador confiável para prever risco mortalidade nesta população (OR 0.921, IC 95% 0.333-2.544, r2 0.0).]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[TAPSE]]></kwd>
<kwd lng="es"><![CDATA[PSAP]]></kwd>
<kwd lng="es"><![CDATA[TAPSE/PSAP]]></kwd>
<kwd lng="es"><![CDATA[disfunción ventricular derecha]]></kwd>
<kwd lng="es"><![CDATA[falla cardiaca derecha]]></kwd>
<kwd lng="es"><![CDATA[acoplamiento ventrículo arterial derecho]]></kwd>
<kwd lng="en"><![CDATA[TAPSE]]></kwd>
<kwd lng="en"><![CDATA[PSAP]]></kwd>
<kwd lng="en"><![CDATA[TAPSE/PSAP]]></kwd>
<kwd lng="en"><![CDATA[right ventricular dysfunction]]></kwd>
<kwd lng="en"><![CDATA[right heart failure]]></kwd>
<kwd lng="en"><![CDATA[right ventricular arterial coupling]]></kwd>
<kwd lng="pt"><![CDATA[TAPSE]]></kwd>
<kwd lng="pt"><![CDATA[PSAP]]></kwd>
<kwd lng="pt"><![CDATA[TAPSE/PSAP]]></kwd>
<kwd lng="pt"><![CDATA[disfunção ventricular direita]]></kwd>
<kwd lng="pt"><![CDATA[insuficiência cardíaca direita]]></kwd>
<kwd lng="pt"><![CDATA[acoplamento arterial do ventrículo direito]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vandenheuvel]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wouters]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[De Hert]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A pathophysiological approach towards right ventricular function and failure]]></article-title>
<source><![CDATA[Eur J Anaesthesiol]]></source>
<year>2013</year>
<volume>30</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>386-94</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cecconi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Johnston]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What role does the right side of the heart play in circulation?]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2006</year>
<volume>10</volume>
<numero>^s3</numero>
<issue>^s3</issue>
<supplement>3</supplement>
<page-range>S5</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haddad]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2008</year>
<volume>117</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1436-48</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poor]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Ventetuolo]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary hypertension in the Intensive Care Unit]]></article-title>
<source><![CDATA[Prog Cardiovasc Dis]]></source>
<year>2012</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>187-98</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trying to succeed when the right ventricle fails]]></article-title>
<source><![CDATA[Curr Opin Cardiol]]></source>
<year>2009</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>239-45</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lahm]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[McCaslin]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Wozniak]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Ghumman]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Fadl]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Obeidat]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical and surgical treatment of acute right ventricular failure]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2010</year>
<volume>56</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1435-46</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greyson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload]]></article-title>
<source><![CDATA[Am J Physiol Heart Circ Physiol]]></source>
<year>2000</year>
<volume>278</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>H1414-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greyson]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Right heart failure in the intensive care unit]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2012</year>
<volume>18</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>424-31</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grignola]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Domingo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute right ventricular dysfunction in Intensive Care Unit]]></article-title>
<source><![CDATA[Biomed Res Int]]></source>
<year>2017</year>
<volume>2017</volume>
<page-range>8217105</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kucher]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[De Rosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Goldhaber]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Massive pulmonary embolism]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2006</year>
<volume>113</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>577-82</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mekontso Dessap]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Boissier]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Charron]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bégot]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Repessé]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Legras]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2016</year>
<volume>42</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>862-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wadia]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Hedstrom]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kovach]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Tandon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early detection of right ventricular dysfunction using transthoracic echocardiography in ARDS: a more objective approach]]></article-title>
<source><![CDATA[Echocardiography]]></source>
<year>2016</year>
<volume>33</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1874-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[López-Palop]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-David]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[García-García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[López-Sendón]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Delcán]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combined effect of age and right ventricular involvement on acute inferior myocardial infarction prognosis]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1998</year>
<volume>98</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1714-20</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O&#8217;Rourke]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Dell&#8217;Italia]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of right ventricular myocardial infarction]]></article-title>
<source><![CDATA[Curr Probl Cardiol]]></source>
<year>2004</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-47</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaul]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
<name>
<surname><![CDATA[Fields]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis]]></article-title>
<source><![CDATA[Cardiovasc Surg]]></source>
<year>2000</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[May]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shlobin]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of right heart failure in the critically ill]]></article-title>
<source><![CDATA[Crit Care Clin]]></source>
<year>2014</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>475-98</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kanwar]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Everett]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Gulati]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brener]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Kapur]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology and management of right ventricular-predominant heart failure and shock in the cardiac intensive care unit]]></article-title>
<source><![CDATA[Eur Heart J Acute Cardiovasc Care]]></source>
<year>2022</year>
<volume>11</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>584-94</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naseem]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alkassas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alaarag]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure]]></article-title>
<source><![CDATA[BMC Cardiovasc Disord]]></source>
<year>2022</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>414</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudski]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[WW]]></given-names>
</name>
<name>
<surname><![CDATA[Afilalo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hua]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Handschumacher]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Chandrasekaran]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>2010</year>
<volume>23</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>685-quiz 786-788</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bleeker]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Steendijk]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Holman]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Breithardt]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Kaandorp]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessing right ventricular function: the role of echocardiography and complementary technologies]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2006</year>
<volume>92</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>i19-26</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rahko]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Blauwet]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Canaday]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Finstuen]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Foster]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>2019</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-64</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parasuraman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Loudon]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Gollop]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Lowery]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of pulmonary artery pressure by echocardiography-A comprehensive review]]></article-title>
<source><![CDATA[Int J Cardiol Heart Vasc]]></source>
<year>2016</year>
<volume>12</volume>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tello]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dalmer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vanderpool]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ghofrani]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Naeije]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension]]></article-title>
<source><![CDATA[Circ Cardiovasc Imaging]]></source>
<year>2019</year>
<volume>12</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Givertz]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of acute right ventricular failure in the intensive care unit]]></article-title>
<source><![CDATA[Curr Heart Fail Rep]]></source>
<year>2012</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>228-35</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Andersen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen-Kudsk]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Levosimendan in pulmonary hypertension and right heart failure]]></article-title>
<source><![CDATA[Pulm Circ]]></source>
<year>2018</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>2045894018790905</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of levosimendan on acute decompensated right heart failure in patients with connective tissue disease-associated pulmonary arterial hypertension]]></article-title>
<source><![CDATA[Front Med (Lausanne)]]></source>
<year>2022</year>
<volume>9</volume>
<page-range>778620</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Wort]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Finney]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Marino]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Brett]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2010</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>R169</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Teboul]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Maggiore]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Vieillard-Baron]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rocco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2006</year>
<volume>34</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2287-93</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bharathi]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Pruthi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dhananjaya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Simha]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of levosimendan on the right ventricular function in patients with right ventricular dysfunction undergoing mitral valve surgery]]></article-title>
<source><![CDATA[Ann Card Anaesth]]></source>
<year>2023</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-6</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sert]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Selcuk]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Yildirimtürk]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Orhan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic value of TAPSE/PASP ratio in right ventricular failure after left ventricular assist device implantation: Experience from a tertiary center]]></article-title>
<source><![CDATA[Turk Gogus Kalp Damar Cerrahisi Derg]]></source>
<year>2022</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>334-43</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[YB]]></given-names>
</name>
<name>
<surname><![CDATA[Hao]]></surname>
<given-names><![CDATA[GZ]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[YF]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[XH]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[WZ]]></given-names>
</name>
<name>
<surname><![CDATA[Miao]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of levosimendan on right ventricular function in patients with acute decompensated heart failure]]></article-title>
<source><![CDATA[Acta Cardiol Sin]]></source>
<year>2019</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>585-91</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toller]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Algotsson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Guarracino]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hormann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Knotzer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lehmann]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perioperative use of levosimendan: best practice in operative settings]]></article-title>
<source><![CDATA[J Cardiothorac Vasc Anesth]]></source>
<year>2013</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>361-6</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Perkins]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McAuley]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Orme]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Santhakumaran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Levosimendan for the prevention of acute organ dysfunction in sepsis]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2016</year>
<volume>375</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>1638-48</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bluro]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Marenchino]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Oberti]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
<name>
<surname><![CDATA[Falconi]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El dilema de Sísifo: la medición del acople ventrículo arterial medido por eco Doppler predice la incidencia de falla de VD post trasplante cardíaco mejor que el cateterismo derecho]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2017</year>
<volume>85</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>527-33</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cursack]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coronel]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Echazarreta]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lobo Márquez]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Lema]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disfunción grave de ventrículo derecho por ecocardiografía en hipertensión arterial pulmonar: prevalencia, predictores clínicos, ecocardiográficos y tratamiento]]></article-title>
<source><![CDATA[Insuf Card]]></source>
<year>2017</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-23</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tello]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Axmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ghofrani]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Naeije]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Narcin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rieth]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2018</year>
<volume>266</volume>
<page-range>229-35</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ishii]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Minatsuki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hatano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saito]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yagi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shimbo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2023</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3758</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
